BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9388817)

  • 1. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.
    Woods KA; Fraser NC; Postel-Vinay MC; Savage MO; Clark AJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1686-90. PubMed ID: 8626815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM; Julius JR; Stoppani C; Rundle AC
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
    Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
    Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
    Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
    Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.
    Klammt J; Shen S; Kiess W; Kratzsch J; Stobbe H; Vogel M; Luo F; Pfäffle R
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):453-61. PubMed ID: 25196842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
    Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum growth hormone-binding protein (GHBP) activity is decreased by administration of insulin-like growth factor I in three Laron syndrome siblings with normal GHBP.
    Silbergeld A; Klinger B; Keret R; Eshet R; Almonté AS; Laron Z
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):324-7. PubMed ID: 8016174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein.
    Rughani A; Zhang D; Vairamani K; Dauber A; Hwa V; Krishnan S
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):331-337. PubMed ID: 31883394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome.
    Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ
    J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
    Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG; Ropelato MG; Domené HM; Pennisi P; Heinrich JJ; Jasper HG
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.